Cargando…

High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!

Detalles Bibliográficos
Autores principales:	van Dam, Peter A., Huizing, Manon, Papadimitriou, Kostantinos, Prenen, Hans, Peeters, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416784/ https://www.ncbi.nlm.nih.gov/pubmed/32927375 http://dx.doi.org/10.1016/j.ejca.2020.07.021

Ejemplares similares

SARS-CoV-2 and cancer: Are they really partners in crime?
por: van Dam, Peter A., et al.
Publicado: (2020)

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
por: Debie, Yana, et al.
Publicado: (2022)

Glucose-6-phosphate dehydrogenase deficiency and SARS-CoV-2 mortality: Is there a link and what should we do?
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020)

Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests
por: van Dam, Peter, et al.
Publicado: (2021)

Hearing Loss in SARS-CoV-2: What Do We Know?
por: Saniasiaya, Jeyasakthy
Publicado: (2021)

Don’t blame the nails for SARS-CoV-2 hospitalizations and mortality
por: Desai, Amar D., et al.
Publicado: (2022)

Facing the SARS-CoV-2 Outbreak: What Should Obstetricians and Gynecologists Do?
por: Zhang, Hongyuan, et al.
Publicado: (2020)

Asymptomatic SARS-CoV-2 infections: What do we need to know?
por: Tan, Caixia, et al.
Publicado: (2020)

Do not miss Bickerstaff encephalitis as a complication of SARS-CoV-2 vaccines
por: Finsterer, Josef, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

Response to “Do not miss Bickerstaff encephalitis as a complication of SARS-CoV-2 vaccines”()
por: Yarmahmoodi, Fatemeh, et al.
Publicado: (2022)

128 days of SARS-CoV-2 viral shedding in a haemodialysis patient
por: Heylen, Line, et al.
Publicado: (2021)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

Indications and timing for tracheostomy in patients with SARS CoV2-related
por: Ferri, Emanuele, et al.
Publicado: (2020)

Seropositivity for SARS-CoV-2 in a General Population: How Specific Is the Diagnostic?
por: Lyu, Zhaoqing, et al.
Publicado: (2023)

Encephalitis associated with the SARS-CoV-2 virus: A case report
por: Vandervorst, Fenne, et al.
Publicado: (2020)

Do matrix metalloproteases mediate the SARS-CoV-2-related damage to the central nervous system?
por: Bongetta, Daniele, et al.
Publicado: (2020)

Are symptoms associated with SARS-CoV-2 infections evolving over time?
por: Ricco, M., et al.
Publicado: (2022)

SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality
por: Kelleni, Mina T.
Publicado: (2021)

Quasi-Simpson paradox in estimating the expected mortality rate from the SARS-CoV-2
por: Shaki, Yair Y
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

SARS-CoV-2: a general recommendation to adhere to government regulations cannot be evidence-based
por: Kampf, G., et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Altitude does not protect against SARS‐CoV‐2 infections and mortality due to COVID‐19
por: Cardenas, Laura, et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

The tele-transition of toxicity management in routine oncology care during the severe acute respiratory syndrome (SARS-CoV-2) pandemic
por: Rasschaert, Marika, et al.
Publicado: (2021)

Is the outcome of SARS-CoV-2 infection in solid organ transplant recipients really similar to that of the general population?
por: Mendoza, Maria A., et al.
Publicado: (2021)

COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans
por: Frutos, Roger, et al.
Publicado: (2020)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

It is not the time to relax yet: masks are still needed for the Omicron variant of SARS-CoV-2
por: Lowe, Scott, et al.
Publicado: (2022)

Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2?
por: Ribeiro, Igor Braga, et al.
Publicado: (2021)

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK
por: Kow, Chia Siang, et al.
Publicado: (2021)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_415vboled75ou1u77motq6eman